![All lanes : Anti-TAFD1 antibody - N-terminal (ab174983) at 1/100 dilutionLane 1 : NCI-H292 cell lysateLane 2 : Mouse liver lysateLane 3 : Jurkat cell lysateLysates/proteins at 15 µg per lane.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_5/8230_ab174983-200377-ab174983WB1.jpg)
All lanes : Anti-TAFD1 antibody - N-terminal (ab174983) at 1/100 dilutionLane 1 : NCI-H292 cell lysateLane 2 : Mouse liver lysateLane 3 : Jurkat cell lysateLysates/proteins at 15 µg per lane.
![Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human lung carcinoma tissue labeling TAFD1 with ab174983 at 1/50 dilution, followed by peroxidase conjugation of the secondary antibody and DAB staining.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_5/8231_ab174983-200378-ab174983IHC1.jpg)
Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human lung carcinoma tissue labeling TAFD1 with ab174983 at 1/50 dilution, followed by peroxidase conjugation of the secondary antibody and DAB staining.
![Flow cytometric analysis of Jurkat cells labeling TAFD1 with ab174983 at 1/10 dilution (bottom histogram) compared to negative control cells (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.](http://www.bioprodhub.com/system/product_images/ab_products/2/sub_5/8232_ab174983-200379-ab174983FC1.jpg)
Flow cytometric analysis of Jurkat cells labeling TAFD1 with ab174983 at 1/10 dilution (bottom histogram) compared to negative control cells (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.